The FDA is concerned that there is little evidence that Testosterone Replacement Therapy is effective for age-related hypogonadism. Eli Lilly is currently sponsoring a clinical trial that could provide supporting evidence.
http://www.clinicaltrials.gov/ct2/show/study/NCT01816295?term=TSAT&rank=37&view=record
What are the odds of an industry-funded trial yielding positive results? Surely you cannot tell, right?
Well, the cynical amongst us may suggest that it's 85%:
http://www.salon.com/2013/01/27/bad_pharma_drug_research_riddled_with_half_truths_omissions_lies/
- Forums
- ASX - By Stock
- Ignore the FDA and buy Acrux
The FDA is concerned that there is little evidence that...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ACR (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.40M |
Open | High | Low | Value | Volume |
5.3¢ | 5.3¢ | 5.3¢ | $20.51K | 387.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 5.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.6¢ | 1974 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 0.053 |
1 | 168669 | 0.052 |
2 | 217490 | 0.050 |
1 | 88000 | 0.048 |
1 | 22222 | 0.045 |
Price($) | Vol. | No. |
---|---|---|
0.056 | 1974 | 1 |
0.058 | 17257 | 1 |
0.060 | 670 | 1 |
0.061 | 100000 | 1 |
0.062 | 116100 | 2 |
Last trade - 15.41pm 31/10/2024 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |